Patents by Inventor Loise Francisco

Loise Francisco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS
    Publication number: 20230302061
    Abstract: Provided herein are methods and pharmaceutical compositions related to the bacteria and microbial extracellular vesicles (mEVs) of Fournierella massiliensis that are useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 28, 2023
    Inventors: Alicia Ballok, Loise Francisco-Anderson, Kevin Huynh, Valeria Kravitz, Audrey McBride, Tyler Rommel, Maria Sizova
  • COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING OSCILLOSPIRACEAE MICROBIAL EXTRACELLULAR VESICLES
    Publication number: 20230263838
    Abstract: Provided herein are methods and pharmaceutical compositions related to microbial extracellular vesicles (mEVs) obtained from Oscillospiraceae bacteria that can be useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2021
    Publication date: August 24, 2023
    Inventors: Alicia Ballok, Loise Francisco-Anderson, Maria Sizova
  • COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING HARRYFLINTIA ACETISPORA
    Publication number: 20230218683
    Abstract: Provided herein are methods and pharmaceutical compositions related to the bacteria and microbial extracellular vesicles (mEVs) of Harryflintia acetispora that are useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Alicia Ballok, Loise Francisco-Anderson, Kevin Huynh, Valeria Kravitz, Audrey McBride, Tyler Rommel, Maria Sizova
  • PROCESSED MICROBIAL EXTRACELLULAR VESICLES
    Publication number: 20220296654
    Abstract: Provided herein are methods and pharmaceutical compositions related to processed microbial extracellular vesicles (pmEVs) that can be useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2020
    Publication date: September 22, 2022
    Inventors: Alicia Ballok, Mark Bodmer, Baundauna Bose, Sofia M. Carlton, Taylor A. Cormack, Christopher J.H. Davitt, Loise Francisco-Anderson, Brian Goodman, Andrea ltano, Nihal Okan, Holly Ponichtera, Erin B. Troy, Fabian B. Romano-Chernac, Maria Sizova
  • SECRETED MICROBIAL EXTRACELLULAR VESICLES
    Publication number: 20220249579
    Abstract: Provided herein are methods and pharmaceutical compositions related to secreted microbial extracellular vesicles (smEVs) that can be useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2020
    Publication date: August 11, 2022
    Inventors: Alicia Ballok, Mark Bodmer, Baundauna Bosse, Sofia M. Carlton, Taylor A. Cormack, Christopher J. Davitt, Loise Francisco-Anderson, Brian Goodman, Andrea Itano, Nihal Okan, Holly Ponichtera, Erin B. Troy, Fabian B. Romano-Chernac, Maria Sizova
  • Agents that modulate immune cell activation and methods of use thereof
    Patent number: 11359020
    Abstract: The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: June 14, 2022
    Assignees: Dana-Farber Cancer Institute, Inc., President and Fellows of Harvard College, Children's Medical Center Corporation
    Inventors: Gordon J. Freeman, Arlene H. Sharpe, Yanping Xiao, Loise Francisco, Rosemarie Dekruyff, Dale Umetsu
  • AGENTS THAT MODULATE IMMUNE CELL ACTIVATION AND METHODS OF USE THEREOF
    Publication number: 20200095325
    Abstract: The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.
    Type: Application
    Filed: September 16, 2019
    Publication date: March 26, 2020
    Inventors: Gordon J. Freeman, Arlene H. Sharpe, Yanping Xiao, Loise Francisco, Rosemarie Dekruyff, Dale Umetsu
  • Agents that modulate immune cell activation and methods of use thereof
    Patent number: 10457733
    Abstract: The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: October 29, 2019
    Assignees: Dana-Farber Cancer Institute, Inc., President and Fellows of Harvard College
    Inventors: Gordon J. Freeman, Arlene H. Sharpe, Yanping Xiao, Loise Francisco, Rosemarie Dekruyff, Dale Umetsu
  • Agents That Modulate Immune Cell Activation and Methods of Use Thereof
    Publication number: 20150299322
    Abstract: The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.
    Type: Application
    Filed: August 2, 2013
    Publication date: October 22, 2015
    Applicants: Dana-Farber Cancer Institute, Inc., Boston Children's Hospital, President and Fellows of Harvard College
    Inventors: Gordon J. Freeman, Arlene H. Sharpe, Yanping Xiao, Loise Francisco, Rosemarie Dekruyff, Dale Umetsu